Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMED CORPCHE · Entity 3723 | Director | July 31, 2026 | August 03, 2026 |
| Tonix Pharmaceuticals Holding Corp.TNXP · Entity 6169 | Director | May 06, 2019 | May 08, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMED CORP
Report date July 31, 2026 · Filed August 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital StockSEC Table I · non-derivative | Direct | 3,533 |
Reported balance
After 2026-07-31 transaction · row 1
1 source rowRow 1 · 2026-07-31 · Sale · Disposed 190 · Balance 3,533 |
Tonix Pharmaceuticals Holding Corp.
Report date May 06, 2019 · Filed May 08, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $2.05 · Expires 2029-05-06 | Direct | 30,000 |
Reported balance
After 2019-05-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-05-06 · Grant · Acquired 30,000 · Balance 30,000 F1: The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Aug 3, 2026 18:39 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 190 | $532.00 | $101,080.00 |
DisclosureSEC source: 0001193125-26-330302 · ownership.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,533 Read SEC document |
| May 18, 2026 Filed May 19, 2026 13:32 UTC | CHEMED CORP CHE · Entity 3723 | GrantCapital Stock | 386 | $440.77 | $170,137.22 |
DisclosureSEC source: 0001193125-26-229815 · ownership.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,723 F1 · acquired: Award of stock Read SEC document |
| May 08, 2026 Filed May 8, 2026 19:32 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 60 | $425.78 | $25,546.80 |
DisclosureSEC source: 0001193125-26-214481 · ownership.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,337 Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 15:51 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 150 | $463.39 | $69,508.50 |
DisclosureSEC source: 0001230970-25-000005 · ownership.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,397 Read SEC document |
| May 19, 2025 Filed May 20, 2025 16:07 UTC | CHEMED CORP CHE · Entity 3723 | GrantCapital Stock | 277 | $579.04 | $160,394.08 |
DisclosureSEC source: 0000950170-25-074992 · ownership.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,547 F1 · acquired: Award of stock Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 19:45 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 284 | $540.98 | $153,638.32 |
DisclosureSEC source: 0000950170-24-072940 · ownership.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,270 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.54 to $541.38. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| May 20, 2024 Filed May 21, 2024 15:51 UTC | CHEMED CORP CHE · Entity 3723 | GrantCapital Stock | 284 | $564.34 | $160,272.56 |
DisclosureSEC source: 0000950170-24-062701 · ownership.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,554 F1 · kind: Award of stock Read SEC document |
| May 26, 2023 Filed May 30, 2023 17:52 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 294 | $544.24 | $160,006.56 |
DisclosureSEC source: 0001209191-23-032805 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,270 Read SEC document |
| May 15, 2023 Filed May 16, 2023 17:08 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 294 | $545.69 | $160,432.86 |
DisclosureSEC source: 0001209191-23-029719 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,564 F1 · kind: Award of stock Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 18:28 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 262 | $465.47 | $121,953.14 |
DisclosureSEC source: 0001209191-22-036243 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,270 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $465.31 to $465.58. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 16, 2022 Filed May 17, 2022 18:15 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 262 | $496.25 | $130,017.50 |
DisclosureSEC source: 0001209191-22-029531 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,532 F1 · kind: Award of stock Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 18:09 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 279 | $494.28 | $137,904.12 |
DisclosureSEC source: 0001209191-21-063068 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,270 Read SEC document |
| May 17, 2021 Filed May 18, 2021 15:42 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 270 | $482.66 | $130,318.20 |
DisclosureSEC source: 0001209191-21-033409 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,549 F1 · kind: Award of stock Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 18:22 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 200 | $451.04 | $90,208.00 |
DisclosureSEC source: 0001209191-20-038112 · doc4.xml · nonDerivative · entry 3 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,279 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $451.00 to $451.08. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 18:22 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 920 | $450.29 | $414,266.80 |
DisclosureSEC source: 0001209191-20-038112 · doc4.xml · nonDerivative · entry 2 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,479 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $449.91 to $450.89. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 18:22 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 400 | $449.48 | $179,792.00 |
DisclosureSEC source: 0001209191-20-038112 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,399 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $448.87 to $449.83. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| May 18, 2020 Filed May 19, 2020 16:23 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 279 | $466.43 | $130,133.97 |
DisclosureSEC source: 0001209191-20-030343 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,799 F1 · kind: Award of stock Read SEC document |
| August 07, 2019 Filed Aug 7, 2019 16:18 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 257 | $415.43 | $106,765.51 |
DisclosureSEC source: 0001209191-19-044923 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,520 Read SEC document |
| May 20, 2019 Filed May 22, 2019 15:41 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 257 | $331.69 | $85,244.33 |
DisclosureSEC source: 0001209191-19-031932 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,777 F1 · kind: Award of stock Read SEC document |
| May 06, 2019 Filed May 8, 2019 11:58 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | GrantStock Option · Derivative | 30,000 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001387131-19-003422 · ownership.xml · derivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-05-06 F1 · price: The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan. F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan. Read SEC document |
| June 22, 2018 Filed Jun 22, 2018 19:05 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 250 | $323.76 | $80,940.00 |
DisclosureSEC source: 0001209191-18-039142 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,520 Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 21:18 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001615774-18-005238 · s110818_form4.xml · derivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-12 F1 · price: The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan. F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan. Read SEC document |
| May 21, 2018 Filed May 23, 2018 17:50 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 255 | $333.75 | $85,106.25 |
DisclosureSEC source: 0001209191-18-032518 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,770 F1 · kind: Award of stock Read SEC document |
| October 02, 2017 Filed Oct 2, 2017 18:26 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 500 | $201.48 | $100,740.00 |
DisclosureSEC source: 0001209191-17-054512 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,515 Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 21:00 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0001615774-17-003290 · s106636_form4.xml · derivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-06-20 F1 · price: The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan. Read SEC document |
| May 27, 2017 Filed Mar 9, 2018 20:35 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001754 · s109299_form4.xml · derivative · entry 4 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On May 27, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date. F2 · derivative.expiration_date: On May 27, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date. Read SEC document |
| May 27, 2017 Filed Mar 9, 2018 20:35 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionCommon Stock, $0.001 par value | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001754 · s109299_form4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 15, 2017 Filed May 16, 2017 18:15 UTC | CHEMED CORP CHE · Entity 3723 | Grantcapital stock | 418 | $203.52 | $85,071.36 |
DisclosureSEC source: 0001209191-17-032560 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,015 F1 · kind: Award of stock Read SEC document |
| February 09, 2017 Filed Mar 9, 2018 20:35 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001754 · s109299_form4.xml · derivative · entry 5 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On February 9, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date. F3 · derivative.expiration_date: On February 9, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date. Read SEC document |
| February 09, 2017 Filed Mar 9, 2018 20:35 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionCommon Stock, $0.001 par value | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001754 · s109299_form4.xml · nonDerivative · entry 2 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 28, 2016 Filed Nov 28, 2016 19:12 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 400 | $148.53 | $59,412.00 |
DisclosureSEC source: 0001209191-16-152140 · doc4.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,597 Read SEC document |
| February 25, 2016 Filed Mar 9, 2018 20:35 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001754 · s109299_form4.xml · derivative · entry 6 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 600 restricted stock units, vesting in on the first anniversary of the grant date. F4 · derivative.expiration_date: On February 25, 2015, the reporting person was granted 600 restricted stock units, vesting in on the first anniversary of the grant date. Read SEC document |
| February 25, 2016 Filed Mar 9, 2018 20:35 UTC | Tonix Pharmaceuticals Holding Corp. TNXP · Entity 6169 | Exercise / conversionCommon Stock, $0.001 par value | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001754 · s109299_form4.xml · nonDerivative · entry 3 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.